Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Grundman

San Diego, CA Medical Doctor

CMS profile 1287745

13236 Haxton Pl, San Diego, CA 92130

Open in the dashboard

General payments

$1,492,385

21 records reported · program years 2019–2025

Research payments

$29,250

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Grundman of San Diego, CA is reported in the CMS Open Payments database as having received $1,492,385 across 21 general payments and $29,250 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $87,500 1
2024 General $350,000 4
2023 General $350,000 4
2022 General $350,150 5
2021 General $350,000 4
2019 General $4,735 3
2019 Research $29,250 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Grundman
  • California median
  • Middle half of California
  • National median

In program year 2025, general payments to Michael Grundman were reported at $87,500. Among 98,626 California profiles paid that year, the median was $172 and the middle half received between $54 and $610.

Show as a table
Year Michael Grundman California median Middle half National median
2019 $4,735 $161 $50–$652 $163
2020 $0 $114 $34–$392 $114
2021 $350,000 $137 $41–$509 $132
2022 $350,150 $152 $48–$573 $149
2023 $350,000 $162 $50–$581 $160
2024 $350,000 $162 $52–$583 $164
2025 $87,500 $172 $54–$610 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Genentech, Inc. $1,487,500 17 payments
  2. Biogen, Inc. $4,735 3 payments
  3. Genentech USA, Inc. $150 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,492,225 19 payments
  2. Food and Beverage $150 1 payment
  3. Education $10 1 payment
Research payments came from Research payments · program years 2019–2025
  1. Biogen, Inc. $29,250 1 payment

Records

22 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record